Trial Profile
The real life clinical study to assess the effectiveness of everolimus plus exemestane treatment.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Jul 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary) ; Exemestane (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 06 Jul 2018 New trial record